About Us

Welcome to TaP Pharmaceuticals AG!
Established in 2017 and headquartered in Switzerland, TaP Pharmaceuticals AG is committed to advancing global healthcare through cutting-edge pharmaceutical research. Our U.S. operations are conducted under Axar Laboratories Inc., our wholly owned, expanding our global reach and impact. Our India operations at the present time are under exclusive development service agreement with TaP.
We specialize in end-to-end pharmaceutical development, from concept to commercialization (C2C). Our services include formulation, process development, packaging, sourcing, analytical services, clinical trials, regulatory strategy, and intellectual property management. Whether starting new projects or enhancing existing ones, we provide a seamless journey from idea to market.






Our Mission & Vision
Our Vision
Our Mission
Meet Our Leadership Team

Neil H. Parikh, Ph.D.
CEO/ President

Neil H. Parikh, Ph.D.

William C. Hite
Vice President, Corporate Development
& Portfolio Management

William C. Hite

John Burr, Ph.D./J.D.
Senior Legal
& Intellectual Property Counsel

John Burr, Ph.D./J.D.

Kartik Shah, Ph.D.
R&D (Generics)

Kartik Shah, Ph.D.

Binaya Das, Ph.D.
General Manager, Quality Assurance

Binaya Das, Ph.D.

Megha Swami
Lead, Business Development
